HDAC6-IN-22 (compound 30), an HDAC6 inhibitor, exhibits an IC50 of 4.63 nM and demonstrates antiproliferative effects against multiple myeloma both in vitro and in vivo. It induces cell cycle arrest in the G2 phase and promotes apoptosis via the mitochondrial pathway [1].
Molecular Weight:
400.47
Formula:
C24H24N4O2
Target:
HDAC|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
